{
    "2020-04-28": [
        [
            {
                "time": "2019-04-30",
                "original_text": "【广证恒生】大参林（603233）-年报&季报点评-2019年稳步扩张高增长，一季度52%增长超市场预期",
                "features": {
                    "keywords": [
                        "大参林",
                        "年报",
                        "季报",
                        "稳步扩张",
                        "高增长",
                        "超预期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-06",
                "original_text": "A股异动 | 大参林涨6.65% 股价刷新其上市以来新高",
                "features": {
                    "keywords": [
                        "大参林",
                        "股价",
                        "新高"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-07",
                "original_text": "大参林：一季度业绩大超预期，现金充裕有望加速扩张【国盛医药张金洋团队】",
                "features": {
                    "keywords": [
                        "大参林",
                        "一季度",
                        "业绩",
                        "超预期",
                        "现金充裕",
                        "加速扩张"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-08",
                "original_text": "大参林(603233.SH)：一季度净利升52.28%至2.8亿元",
                "features": {
                    "keywords": [
                        "大参林",
                        "一季度",
                        "净利",
                        "上升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-09",
                "original_text": "大参林(603233.SH)：2019年净利升32.17%至7.03亿元 拟10转2派6元",
                "features": {
                    "keywords": [
                        "大参林",
                        "2019年",
                        "净利",
                        "上升",
                        "分红"
                    ],
                    "sentiment_score": 0.92,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-10",
                "original_text": "大参林：一季度净利润同比增长53.27%",
                "features": {
                    "keywords": [
                        "大参林",
                        "一季度",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-11",
                "original_text": "【天风证券】大参林：一季度业绩超预期，“内生+外延”推动公司长期发展",
                "features": {
                    "keywords": [
                        "大参林",
                        "一季度",
                        "业绩",
                        "超预期",
                        "内生",
                        "外延",
                        "长期发展"
                    ],
                    "sentiment_score": 0.93,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}